Jubilant Pharmova

NSE

Concord Biotech

NSE

TLDR: Quick Comparison Summary

Based on 13 vital metrics comparison: Jubilant Pharmova wins in 5 metrics, Concord Biotech wins in 7 metrics, with 0 ties. Concord Biotech appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Jubilant Pharmova	Concord Biotech	Better
P/E Ratio (TTM)	21.22	50.77	Jubilant Pharmova
Price-to-Book Ratio	2.84	10.39	Jubilant Pharmova
Debt-to-Equity Ratio	43.78	0.16	Concord Biotech
PEG Ratio	0.02	N/A	N/A
EV/EBITDA	16.32	37.34	Jubilant Pharmova
Profit Margin	11.60%	30.97%	Concord Biotech
Operating Margin	12.97%	40.90%	Concord Biotech
EBITDA Margin	12.97%	40.90%	Concord Biotech
Return on Equity	14.35%	22.26%	Concord Biotech
Return on Assets	4.14%	15.13%	Concord Biotech
Free Cash Flow	$-435.00M	$1.33B	Concord Biotech
Dividend Yield	0.45%	0.44%	Jubilant Pharmova
1-Year Return	58.90%	3.21%	Jubilant Pharmova

Overview

Performance

Valuation

Financials

Short Interest

Dividends

Jubilant Pharmova vs Concord Biotech Price History Comparison

Loading Price Chart...

Key Statistics Comparison

Loading Statistics...

Performance

Jubilant Pharmova vs Concord Biotech Performance Comparison Chart

Loading Price Chart...

Performance Comparison

Loading Performance Data...

Valuation

Valuation History

Loading Valuation History...

Market Capitalization % Change

P/E Ratio (TTM)

Forward P/E

PEG Ratio

Price to Sales (TTM)

Price to Book (MRQ)

Enterprise Value % Change

EV/EBITDA

EV/Revenue

Valuation Metrics

Loading Valuation Metrics...

Financials

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement Comparison (TTM)

Loading Financials...

Income Statement (MRQ)

Balance Sheet & Liquidity Metrics (MRQ)

Cash Flow Statement Comparison (MRQ)

Short Interest And Ownership

Short Interest And Ownership Metrics

Loading Short Interest And Ownership Data...

Dividends

Dividend Information

Loading Dividend Information...

Metric	JUBLPHARMA	CONCORDBIO
Market Information
Market Cap i
10 Day Avg. Volume i
90 Day Avg. Volume i
Last Close i
52 Week Range i
Valuation Metrics
P/E Ratio (TTM) i
Forward P/E i
PEG Ratio i
Price to Sales (TTM) i
Price to Book (MRQ) i
Financial Health
Profit Margin i
Operating Margin i
Return on Equity (TTM) i
Debt to Equity (MRQ) i
Dividends
Last 12-Month Dividend Yield i
Last 12-Month Dividend i

Stock	1D	1W	1M	3M	6M	YTD

Stock	1Y	3Y	5Y	10Y	15Y	20Y

Metric	JUBLPHARMA	CONCORDBIO
Shares Shorti	-	-
Short Ratioi	-	-
Short % of Floati	-	-
Average Daily Volume (10 Day)i	-	-
Average Daily Volume (90 Day)i	-	-
Shares Outstandingi	-	-
Float Sharesi	-	-
% Held by Insidersi	-	-
% Held by Institutionsi	-	-

Metric	JUBLPHARMA	CONCORDBIO
Last 12-Month Dividend	-	-
Last 12-Month Dividend Yield	-	-
3-Year Avg Annual Dividend	-	-
3-Year Avg Dividend Yield	-	-
3-Year Total Dividends	-	-
Ex-Dividend Date	-	-

Jubilant Pharmova [JUBLPHARMA] vs Concord Biotech [CONCORDBIO] Detailed Comparison